4
Clinical Trials associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin CalciumReduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia: a Multi-center-database Real-world Study
This study is a large-scale, prospective, multi-center, and non-interventional observation study to observe blood pressure and blood lipid changes and safety during administration of olomax tablets for 24 weeks in hypertensive patients with dyslipidemia.
A Multi-center, Randomized, Open-label, Active-controlled, Phase IV Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab in Hypertension Patients With Low-Intermediate Risk for Cardiovascular Disease
The purpose of this study is to evaluate the efficacy and safety of OLOMAX Tab (20/5/5mg, 20/5/10mg) in Hypertension Patients with Low-Intermediate Risk for Cardiovascular Disease.
A Multi-center, Randomized, Double-blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
A multi-center, randomized, double-blind, phase III clinical trial to evaluate the efficacy and safety of Olmesartan/Amlodipine/Rosuvastatin combination treatment in patients with concomitant hypertension and hyperlipidemia
100 Clinical Results associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
100 Translational Medicine associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
100 Patents (Medical) associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium
100 Deals associated with Amlodipine Besylate/Olmesartan Medoxomil/Rosuvastatin Calcium